Literature DB >> 30803970

Serum Levels of Crushed Posaconazole Delayed-Release Tablets.

Mathew J Mason1, Patrick M McDaneld2, William L Musick1, Dimitrios P Kontoyiannis3.   

Abstract

Entities:  

Keywords:  posaconazole; therapeutic drug monitoring

Year:  2019        PMID： 30803970      PMCID： PMC6496040          DOI： 10.1128/AAC.02688-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  "Avoid the crush": hazards of medication administration in patients with dysphagia or a feeding tube.

Authors:  Patricia Cornish
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

2.  Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses.

Authors:  Frank P Tverdek; Sang Taek Heo; Samuel L Aitken; Bruno Granwehr; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension.

Authors:  Gopal Krishna; Lei Ma; Monika Martinho; Edward O'Mara
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 4.  Pharmacologic and clinical evaluation of posaconazole.

Authors:  Jason N Moore; Jason R Healy; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2015-05       Impact factor: 5.045

Review 5.  Therapeutic Drug Monitoring of Posaconazole: an Update.

Authors:  Bart G J Dekkers; Martijn Bakker; Kim C M van der Elst; Marieke G G Sturkenboom; Anette Veringa; Lambert F R Span; Jan-Willem C Alffenaar
Journal:  Curr Fungal Infect Rep       Date:  2016-05-07

6.  A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers.

Authors:  G Krishna; L Ma; M Martinho; R A Preston; E O'Mara
Journal:  J Antimicrob Chemother       Date:  2012-07-24       Impact factor: 5.790

Review 7.  Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections.

Authors:  Nathan P Wiederhold
Journal:  Clin Pharmacol       Date:  2015-12-23

8.  Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.

Authors:  Whitley M Yi; Kelly E Schoeppler; Jaclyn Jaeger; Scott W Mueller; Robert MacLaren; Douglas N Fish; Tyree H Kiser
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-09-11       Impact factor: 3.944
  8 in total
  3 in total

1.  Saprochaete clavata Invasive Infections - A New Threat to Hematological-Oncological Patients.

Authors:  Vladimir Buchta; Radka Bolehovská; Eva Hovorková; Oliver A Cornely; Danila Seidel; Pavel Žák
Journal:  Front Microbiol       Date:  2019-10-29       Impact factor: 5.640

2.  How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.

Authors:  Kelli A Cole; Anna Y Zhou; Travis Jones; W Justin Moore; Elisabeth L Chandler; Veronica B Zafonte; Taylor Morrisette; Timothy P Gauthier; Jamie Kisgen; Amanda Barner; Melissa D Johnson; R Dawn Tagare; Julie Ann Justo
Journal:  Clin Infect Dis       Date:  2022-05-15       Impact factor: 20.999

3.  Precision Therapy for Invasive Fungal Diseases.

Authors:  Anne-Grete Märtson; Jan-Willem C Alffenaar; Roger J Brüggemann; William Hope
Journal:  J Fungi (Basel)       Date:  2021-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.